BioSpace News Archive

Shattuck Labs, Inc. reported financial results for the quarter ended March 31, 2023, and provided recent business highlights.

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, announced first quarter 2023 results and provided a corporate update.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing innovative therapies for the localized treatment of patients with chronic rhinosinusitis, announced that Maria Palasis, Ph.D., President and Chief Executive Officer, will present at the Bank of America Securities 2023 Healthcare Conference on Wednesday, May 10, 2023, at 4:35 p.m. PT.

Senti Biosciences, Inc., a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit platform, reported financial results for the first quarter of 2023.

4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, announced the closing of an upsized underwritten public offering of 8,625,000 shares of its common stock at a public offering price of $16.00 per share.

Olema Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Poseida Therapeutics, Inc. (Nasdaq: PSTX) today announced updates and financial results for the first quarter ended March 31, 2023.

Azenta, Inc. reported financial results for the second quarter ended March 31, 2023.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to five new employees.

Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, announced financial results for the three months ended March 31, 2023.